Patent Assignment
Reel/Frame 015595/0486
Assignment of Assignor's Interest
Recorded: 2004-06-14
Pages: 20
Assignee
IOMED, INC.
2441 SOUTH 3850 WEST, SUITE A, SALT LAKE CITY, UTAH, 84120-9941
Covered Property
(1)
The Use of 5-Fluorourcil, Delivered by Iontophoresis as an Inhibitor of Cell Proliferation in the Eye, Bulbar and Palpebral Conjunctiva, Eyelid, Peri-Orbital Soft Tissues and Skin
Application:
10/707,794 →
Publication:
US 2005/0153994
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 10, 2007
From: IOMED, LLC (F/K/A IOMED, INC.)
To: ENCORE MEDICAL ASSET CORORATION
Reel/Frame 019795/0561 →
Security Agreement
Nov 15, 2007
From: REABLE THERAPEUTICS HOLDINGS LLC; REABLE THERAPEUTICS FINANCE LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 020112/0579 →
Security Agreement
Dec 13, 2007
From: ENCORE MEDICAL ASSET CORPORATION
To: CREDIT SUISSE, AS COLLATERAL AGENT
Reel/Frame 020234/0433 →
Release of Security Interest
May 18, 2015
From: CREDIT SUISSE AG, AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 035706/0497 →
Release by Secured Party
Jan 16, 2019
From: BANK OF AMERICA, N.A.
To: REABLE THERAPEUTICS HOLDINGS LLC; REABLE THERAPEUTICS FINANCE LLC
Reel/Frame 048080/0952 →